Omnicell News

Mountain View, Calif.-based Omnicell, Inc. , is unveiling a medical grade wireless supply mobile cart that it says will enable clinicians to securely access specialty supplies from any location at any time.

In a June 18 story about the performance of shares of companies on the Standard & Poor's SmallCap 600 Index, The Associated Press incorrectly described Omnicell Inc.

“What's good for General Motors is good for the U.S.A.”

Stock buybacks are generally considered a bullish signal on Wall Street. They return capital to shareholders, while declaring management's belief that its own cheap shares are its best return on investment. via Fool.com

Sign up today and access the leading source of Health Care I.T. information on the Web. via Health Data Management

Omnicell, Inc. , Citizens Republic Bancorp, Inc. and AMCORE Financial, Inc. were among the new 52-week lows established during Tuesday's trading among companies with market capitalizations or values under $750 ... via All Stories

Omnicell Disappoints Investors The stock price of hospital software vendor Omnicell Inc. via Health Data Management

Omnicell, Inc. , Zoran Corp. and TomoTherapy Inc. are among the most actively traded companies in Tuesday's pre-market trading among those with market capitalizations under $750 million. via All Stories

Omnicell, Inc. , a leading provider of system solutions to acute healthcare facilities, will hold a conference call Monday, April 21 to discuss the company's first quarter 2008 financial results. via Imaging Magazine

“This decision reflects our belief that our common stock is undervalued and does not reflect the intrinsic value of Omnicell, its performance and its prospects”

The Company's Board of Directors decided to pursue this course of action after a review of the Company's financial position and investment alternatives. via Earth Times

“Risk Factors", and under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operation", and the "Omnicell Annual Report”

' Chief Financial Officer and VP of Fin. Analysts Glenn Garmont - ' Broadpoint Capital Eugene Goldinberg - ' BB&T Capital Markets Tom Gallucci - ' Merrill Lynch Sean Wieland - ' Piper Jaffray Alan Fishman - ' ... via Seeking Alpha

“Management's conclusion is that the fourth quarter represents an anomaly”

Shares of Omnicell Inc. sank to a year low Friday after the company, which provides medication control and patient safety products, posted fourth-quarter earnings in line with Wall Street's expectations but ... via International Business Times

Shawn Rioux, the college dropout who started a hospital cart factory near Pontiac five years ago, is now a millionaire.

Rioux, 40, completed the sale of his business Wednesday to a Silicon Valley company for $26 million.

Omnicell Inc. plans to keep the Rioux Vision factory and its 60 employees in Pontiac, said Deborah Reinert, a spokeswoman for Mountain View, Calif., company.

Rioux (pronounced Rio) will be leaving the company.

Omnicell has more than 600 employees and has a manufacturing facility in Mountain View, handling final assembly of cabinets and computer equipment for hospital pharmacies, Reinert said. Read more

Hospital technology company Omnicell Inc. agreed to buy Rioux Vision for $26 million in cash. via The San Francisco Business Times

The president and chief executive of Omnicell Inc. sold 20,000 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Tuesday. via Canadian Business Magazine

“It's really the perfect storm (for Omnicell)”

Hospitals are supposed to make you better, but sometimes they make you sicker.

Patients can come down with infections, fall in the hallways or receive the wrong medications.

Patient safety issues are getting more attention from state and federal regulators, as well as the hospital certification body known as the Joint Commission.

The Joint Commission, for example, has made the reduction of drug errors one of its top safety goals for hospitals.

The commission says that medication errors in the U.S. harm about 1.5 million patients a year and are responsible for several thousand deaths, costing the nation at least $3.5 billion a year. Read more